Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Remote In-Home Tele-
Monitoring in Western NSW
2016-2018:
Monica Murray Project Manager – HiTH/Ambulatory Care
Integrated Care Strategy
Western NSW Local Health District
[email protected] 0428641162
Overview
1. Background
2. Trial 1 – WNSW LHD
3. Trial 2 – Aboriginal Health Services
Partnership
4. Barriers, Enablers, Learning
5. Current status & potential
6. Points for consideration
7. Future Vision
What is Remote In-Home
Tele-Monitoring?
• Automated biometric devices in home -
BP, Temp, HR, PO2, BGL, Weight, ECG,
(+-spirometry), +/- videoconference, +/-
targeted health coaching
• Data transmitted to secure website,
checked daily Mon-Fri by local nurse
• Telstra Mobile 3G network
• ↑ NGO’s offer THM under Home Care
Packages & Commonwealth Home
Support
What does the literature say?
Objectives of trials
Process Evaluations
Objective Measure
1. Acceptance and relevance of tele-home monitoring with a variety of clinicians and patients.
Demographics of staff and patient uptake,
2.Useability of tele-home monitoring within a range of existing service delivery models
Pre and post-trial staff confidence and usability with the technology, perceived patient benefits and workload impact
3.Improvements in patient knowledge of symptoms and capacity to self-manage
Patient reported experience
Sites involved
Trial 1: WNSWLHD (May 2016-June 2017)
Bathurst, Orange, Dubbo
Parkes, Cowra
Cobar, Molong, Wellington
Trial 2: Bila Muuji Aboriginal Medical Services
Partnership (Nov 2016- Feb 2018)
Brewarrina, Bourke, Coonamble, Dubbo
Forbes, Orange, Walgett, Wellington
Resources…
TeleMedCare Secure Website
Brief Demographics of Trials
Trial 1 (LHD) May 2016-June 2017
• 8 LHD facilities
• Total 20 enrolments in trial
• 12 Female / 8 Male,
• Median age – 68 yrs
• Length of monitoring:
range 4 day – 138 days
average LOS monitoring – 32 days
• Report available with full details
Trial 2 (Aboriginal Medical Services)
Oct 2017-Feb 2018
• 8 Aboriginal Medical Services
• Total 52 enrolments in trial period
• 65% Female/35% Male
• Median Age – 60-69 yrs (range 23-87yrs)
• 56% used for a month duration
• Report available with full details
Patient evaluations • Overall patient feedback was very positive
in both trials
• 88% rated THM as easy to use
• 88% felt THM improved their knowledge about their health condition & symptoms
• 89% would recommend to others
• 82% felt that THM improved communication with their doctor
• 79% reported LESS anxiety using THM
Challenges
• Rate of technological advances
• Implementation requires significant flexibility, frequent review and adaptation.
• Workforce capacity & readiness site dependent
• Workforce variable skills to manage and escalate biometrics in the community
• Staff comfort/skills with self-management & patient access to additional biometric data
• Limited strong evidence to determine HTM cost/benefit
Enablers
• Additional external funding to purchase and trial technology in partnership model
• Adequately resourced support team
• Local leadership of early adapters, comfort with technology and culture to accommodate change.
Learning for WNSW
Proportion of the population within our region suffering one or more chronic conditions is attributable to remoteness and Aboriginality, the comparative ease in which clients of the Bila Muuji Partnership Trial have been enrolled in HTM is an early success and should be explored further as a means of better managing chronic conditions in WNSW
Current Situation……Bila Muuji
Aboriginal Health Services Partnership
• Partnership Closure April 2018 – planned withdrawal of LHD support
• Aboriginal Medical Services now self-
sustaining their own THM • Average 10-12 patients being monitored
each month
Current situation: WNSW LHD
• Conservatively support current devices until (2020) • Loss of key project staff– didn’t aggressively market
after trial to consider directions/models → low numbers ~ 6/m active patient monitored currently
• Review manuals/protocols • Support new sites to implement THM • West Morton Qld model - visit July 2018.
Future Potential for RIHTM in WNSW
• Patient Flow, Remote Critical Care Consultation & Patient Transport Unit (Dubbo) • Expansion & move to airport. Commence
24/7 2019 with after-hours nurse/doctor • Stage 1 - ‘IN-HOSPITAL Remote Monitoring’
- supporting rural/remote hospitals with IN-HOSPITAL monitoring to assist in detection of clinical deterioration inpatients on wards
• Potential to support IN-HOME monitoring as
subsequent stage
Points for consideration • Gap between perceived/expected enrolments….and actual
• Model of Care – choosing right fit
• Target patients – narrow or broad criteria
• Vendor comparison/variance
• Funding & Activity reporting under ABF
• Governance
• Evaluation
• Other community players
• Change management support & leadership crucial
• Health Coaching/Chronic Disease Management
• Interface with eMR
• Interface with other VC platforms being used by clinicians
Future Vision